Randomized trial demonstrates improved tumor imaging and treatment in hypoxic tumors, suggesting enhanced therapy options.
-sensitive imaging, robust tumor suppression, and potent induction of immunogenic cell death in vivo. Overall, unlike prior approaches that address either tumor imaging or hypoxia modulation alone, this work establishes a versatile sonoafterglow nanobomb for oxygen-independent, image-guided, and synergistic tumor theranostics.
No takes yet. Share an insight, caveat, or question.
Fan et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: